Researchers explored the metabolic features characterizing MYC-driven medulloblastoma and examined how these were altered by BET-bromodomain inhibition.
[Scientific Reports]
Home Newsletters Neural Cell News Metabolic Rewiring in MYC-Driven Medulloblastoma by Bet-Bromodomain Inhibition
